Safety of trastuzumab in women with HER2+breast cancer.

被引：1
|
作者：
Nowsheen, Somaira
Aziz, Khaled
Park, Jae Yoon
Villarraga, Hector R.
Herrmann, Joerg
Ruddy, Kathryn Jean
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e12522
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12522
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Potential Biomarkers Associated with Prognosis and Trastuzumab Response in HER2+Breast Cancer
    Castro-Guijarro, Ana Carla
    Sanchez, Angel Matias
    Flamini, Marina Ines
    Vogel, Christoph F. A.
    [J]. CANCERS, 2023, 15 (17)
  • [22] Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer
    Iwata, H.
    Yamamoto, N.
    Masuda, N.
    Bando, H.
    Kuroi, K.
    Ohno, S.
    Kasai, H.
    Morita, S.
    Sakurai, T.
    Toi, M.
    [J]. BREAST, 2015, 24 : S95 - S95
  • [23] The trastuzumab era: current and upcoming targeted HER2+breast cancer therapies
    Kreutzfeldt, Jordyn
    Rozeboom, Brett
    Dey, Nandini
    De, Pradip
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (04): : 1045 - 1067
  • [24] A gene expression signature that predicts for trastuzumab response in HER2+breast cancer
    Abukhdeir, Abde M.
    Najor, Matthew S.
    Turturro, Sanja B.
    Armstrong, Andrew R.
    McDonald, Andrew
    Fogg, Lou
    Cobleigh, Melody A.
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [25] Impact of race on BluePrint genomic subtyping in HER2+breast cancer.
    Reid, Sonya A.
    Pal, Tuya
    Shu, Xiao-Ou
    Venton, Lindsay
    Whisenant, Jennifer G.
    Hoskins, Kent
    Dias, Eduardo
    Rahman, Rakhshanda Layeequr
    Wei, Jennifer
    Uygun, Sahra
    Singleton, Ciera S.
    Menicucci, Andrea
    Dauer, Patricia
    Audeh, William M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Clinical significance of crown-like structures to trastuzumab response in patients with primary invasive HER2+breast cancer.
    Savva, Constantinos
    Birts, Charles N.
    Laversin, Stephanie A.
    Lefas, Alicia
    Krishnan, Jamie
    Schapira, Aron
    Ashton-Key, Margaret
    Crispin, Max
    Johnson, Peter W. M.
    Blaydes, Jeremy P.
    Copson, Ellen
    Cutress, Ramsey I.
    Beers, Stephen A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Resistance to trastuzumab is associated with alpha-smooth muscle actin expression in the stroma of patients with HER2+breast cancer.
    Vathiotis, Ioannis A.
    Moutafi, Myrto K.
    Divakar, Prajan
    Aung, Thazin Nwe
    Fernandez, Aileen
    Yaghoobi, Vesal
    Shafi, Saba
    Syrigos, Konstantinos N.
    Fountzilas, George
    Pusztai, Lajos
    Warren, Sarah
    Rimm, David L.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [28] Trastuzumab-Induced Tumor Microenvironment Changes in Early HER2+Breast Cancer
    Kennedy, Laura C.
    Alvarez, Rebeca
    Dintzis, Suzanne
    Gadi, Vijayakrishna K.
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [29] Visualizing trastuzumab-deruxtecan action in HER2+breast cancer cells at nanoscale
    Cortese, K.
    Garrone, O.
    Gagliani, M. C.
    Bellese, G.
    Arnaldi, P.
    Abbona, A.
    Paccagnella, M.
    Ruatta, F.
    Merlano, M. C.
    Castagnola, P.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S197 - S197
  • [30] Targeting trastuzumab-resistant HER2+breast cancer with a HER3-targeting nanoparticle
    Sims, Jessica
    Taguaim, Michael
    Hanson, Chris
    Cui, Xiaojiang
    Medina-Kauwe, Lali K.
    [J]. CANCER RESEARCH, 2014, 74 (19)
12345